Enhanced Potential of Myricx's NMT Inhibitor Payloads with Dual Senolytic and Cytotoxic Modes of Action as ADC Cancer Therapies tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Researchers from the Francis Crick Institute, Imperial College London and Astrazeneca are working to advance discovery of ‘molecular glues’ that facilitate interaction between a protein previously considered to be ‘undruggable’ and a cellular enzyme, that is capable of modifying and degrading the disease-causing target protein. Click to read more.